DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Johnson JPCoJ.
U.S. FDA Approves XARELTO® (rivaroxaban) to help prevent blood clots in acutely ill medical patients.
Accessed September 2, 2020
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.